Controllers close the books, FP&A builds the forecast. In most biotechs, those worlds barely talk to each other.
R&D Logic connects them. Actuals from your GL flow directly into planning views. No “why don’t these numbers match” conversations: https://t.co/Y8Dw9ogqbh
Every biotech has more programs than resources. The question is: are you allocating people and dollars based on data or feel?
R&D Logic gives you real-time visibility into resource utilization, who’s allocated where, costs, and more: https://t.co/Y8Dw9ogqbh
It’s reforecast season and six months of actuals and the plan is already stale.
In R&D Logic, your rolling forecast incorporates actuals automatically. Reforecasting is updating assumptions, not model redesign: https://t.co/gnyeDi4wge
Investors fund your science and your financial discipline.
Meaning: clean project-level data, comprehensible cost allocation, real burn visibility, scenario planning.
R&D Logic helps biotechs tell the financial story investors need to hear via real data: https://t.co/Y8Dw9ogqbh
Every biotech has a breaking point. It’s usually “one more program.”
The spreadsheet handling three projects breaks at seven. “Close enough” time tracking now means compliance gaps.
R&D Logic is built for the moment your complexity outgrows your tools: https://t.co/Y8Dw9ogqbh
Spreadsheets are fun until a grant audit finds gaps, a collaborator disputes an invoice, or the board loses confidence in the numbers.
“For now” has a shelf life and R&D Logic is what comes next: https://t.co/Y8Dw9ogqbh
#Biotech#LifeSciences#FPA#CFO
The best biotech finance leaders don’t only close book. They model different moves, answer board questions in real time, and give research leaders financial visibility.
They can do that because their tools let them and R&D Logic is that tool: https://t.co/Y8Dw9ogqbh
R&D Logic isn’t only for early-stage biotechs. Large, complex life science organizations trust R&D Logic for financial planning and multi-dimensional reporting at scale, from Series A to commercial.
One platform: https://t.co/Y8Dw9ogqbh
#Biotech#Pharma#LifeSciences#FPA#CFO
Bad FP&A in biotech means more than inaccurate reports. It presents: mispriced collaborator invoices, understated tax credit claims, or missed grant obligations. And ultimately a board that doesn’t trust the numbers: the stakes for spreadsheets are high: https://t.co/Y8Dw9ogqbh
New to biotech from SaaS or manufacturing? The FP&A is different here.
Life sciences needs project burdening, FTE allocation, grant tracking, collaborator billing, none of which the old tools enjoy. R&D Logic does. Welcome to life sciences FP&A: https://t.co/Y8Dw9ogqbh
VPs of Research shouldn’t have to email finance every time they want to check a project’s burn rate.
Our Dimensions dashboards give research leaders direct, real-time access to the financial data without waiting. Self-serve insight for scientists: https://t.co/HwNngrygTw
A collaborator audit shouldn’t trigger a two-week scramble to reconstruct effort data & cost allocations.
In R&D Logic, this exists in real time: time records, project costs, indirect allocations, approval workflows. All documented and traceable: https://t.co/Y8Dw9ogqbh
When the person who built "The Spreadsheet" leaves, FP&A often turns to chaos without a planning tool. In other words, a single point of failure.
R&D Logic is a system. Documented, auditable, transferable: https://t.co/Y8Dw9ogqbh
#Biotech#LifeSciences#FPA#CFO
Tighter funding. Longer IPO timelines. Boards demanding spend accountability.
Biotechs thriving in this market have real-time visibility into every dollar.
R&D Logic gives you that visibility. Purpose-built for life sciences: https://t.co/hPyHqsIAxI
#Biotech#LifeSciences#FPA
Boards want confidence that the numbers behind the slides are right. R&D Logic gives your CFO a source of truth. Real-time, multi-dimensional, drill-down ready. From corporate P&L to individual transaction. Board-ready by default: https://t.co/3nlmB4XOwd
No one wants to do indirect cost allocation, but everybody needs it done right.
Facilities. IT. G&A. All split across projects based on FTE effort, headcount, or custom rules.
R&D Logic does it automatically every month without spreadsheet gymnastics: https://t.co/mZWGuc3wZh
Your finance team didn’t go into biotech to spend 80% of their time on data assembly.
R&D Logic flips this ratio. Actuals load automatically. Reports generate themselves. Scenarios take minutes: https://t.co/Y8Dw9ofSlJ
#Biotech#LifeSciences#FPA#CFO
When your biotech’s FP&A actually works, a few things can happen. Board decks built in hours, scenarios are modeled before the meeting. Month-end close that feeds analysis automatically.
Finance stops being a bottleneck. That’s R&D Logic: https://t.co/Y8Dw9ogqbh
R&D tax credits can offset millions for pre-revenue biotechs if time and cost data is defensible.
R&D Logic connects project effort tracking to cost allocation giving your tax team the documented, auditable data they need.
Don’t ignore the credits: https://t.co/Y8Dw9ogqbh
Your ERP records what happened. R&D Logic tells you what it means.
Actuals loaded via API. Auto-allocated to projects. Compared against your budget and forecast. Visualized by any dimension.
No CSV exports, copy-paste, or reconciliation gaps: https://t.co/mZWGuc3wZh